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The Editorial on the Research Topic 
Innate Immune Cell Determinants of T Cell Immunity: From Basic Mechanisms to Clinical 
Implications
Long-lasting T cell immunity is delivered by individual T lymphocytes expressing clonally distributed 
antigen-specific receptors. Following priming in lymph nodes, naïve CD4+ and CD8+ T lymphocytes 
proliferate and generate clones of effector cells that deliver unique effector functions in peripheral 
tissues. Moreover, long-lasting memory T cells generated during priming are rapidly engaged upon 
reexposure to the same antigen, even years after their primary induction. Notably, this very efficient 
protection system cannot unfold without accessory cells. Our frontiers research topic features 
different innate immune cell subsets and the crucial roles they play in the initiation and maintenance 
of T cell immunity. By comprehensively describing positive and negative outcomes of these events, 
the contributions provide a meaningful link between basic findings and clinical applications.
t CEll PHYSioloGY dirECtEd BY iNNatE iMMUNE CEllS
Following the seminal discovery of Steinman and Cohn in 1973 (1, 2) describing a rare cell type 
initiating antigen-specific responses, dendritic cells (DC) have taken up the stage for several decades 
as professional antigen-presenting cells (APC). In their reviews, Geginat et  al. and Clausen and 
Stoitzner dissect the instrumental role played by specialized DC subsets in instructing protective 
T cell immunity, emphasizing how this specialization, conserved in mice and humans, suits at best 
the need of dedicated and qualitative different “classes” of T cells for immune homeostasis, defense 
against pathogens, and responses to vaccines and allergens.
Dendritic cells, however, do not stand alone in this process. Indeed, although DC activated 
through pattern-recognition receptors (PRR) are competent for CD4+ T cell priming, they require 
feedback from other T cell subsets, including iNKT, γδT, and CD4+ T helper (Th) cells, for the 
generation of antigen-specific CD8+ T cell immunity. iNKT cells and γδT cells are innate-like T cell 
subsets that recognize lipid and metabolites in a non-MHC-restricted fashion. The contribution of 
Salio and Cerundolo highlights the specific characteristics of these cell types and their modality 
of activation by different tissue-resident APC, focusing on the intracellular pathways that regulate 
lipid and metabolite Ag presentation at steady state and upon infection. The role of these cells in 
“licensing” DC for CD8+ T cell priming is illustrated by Gottschalk et al., presenting a comparative 
functional analysis of DC licensed by iNKT and Th cells.
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Immune responses to infections and other assaults are ini-
tiated in the target tissues. These do not only harbor DC but 
also other immune cell subtypes that are either tissue resident 
or become recruited. Activation of innate immune cells, such 
as mast cells (MC) and neutrophils, will most likely influence 
the activation and polarization of DC, for example, the pattern 
of cytokines expressed by the DC. Thereby, these cells may 
indirectly influence the polarization of naïve T cells by DC in 
the lymph node. In addition, neutrophils have been shown to 
migrate to lymph nodes, where they may directly contribute to 
T cell priming.
Secondary activation is also influenced by innate immune cell 
subsets. For instance, the early phase of infection is character-
ized by a rapid recruitment of neutrophils and monocytes into 
the inflamed tissue, where these phagocytes colocalize with 
tissue-resident memory T cells. In the most recent years, consist-
ent evidences have accumulated in support of the capacity of 
these accessory cells to influence T cell immunity in  vivo. The 
contributions of Leliefeld et al. and Roberts et al. address the role 
of, respectively, neutrophils and monocytes as “bystander activa-
tors” that favor survival and activation of T cells, independently 
of TCR antigen specificity. Notably, both cell types can also act 
as APC delivering Ag-specific and costimulatory signals to T 
cells, and their collaborative endeavors were found to positively 
and negatively modulate the activity of different effector T cell 
subsets, including conventional and innate-like T cells. Moreover, 
neutrophils and monocytes may differentiate and acquire different 
functional programs in response to signals provided by activated 
T cells and influence the quality of T cell responses even at later 
stages of infections and malignant transformation.
At barrier sites T cell responses become modulated also by the 
activity of tissue-resident MC, basophils, and innate lymphoid 
cells (ILC) through their bidirectional interaction with T cells.
Basophils and MC, originally regarded as “degranulating” 
inflammatory cells rapidly responding to the triggering of PRR, 
are now recognized to participate in the regulation of T cell 
immunity. The contributions of Sarfati et al. and Bulfone-Paus and 
Bahri feature the capacity of these two cell subsets to skew naïve 
T cell priming and modulate effector T cell responses by acting as 
cytokine-secreting bystanders in coordination with DC, as well as 
by physically interacting with T lymphocytes. The availability of 
suitable animal models, described by Otsuka and Kabashima, has 
increased our understanding of basophils as putative specialized 
APC for low-molecular-weight compounds, as compared to MC, 
although these findings await confirmation for human basophils.
Intriguingly, the effect of basophils and MC on the tissue 
microenvironment affects also the survival and activity of ILC. 
This is a heterogeneous family of rare immune cells, compre-
hensively described in the review of Von Burg et  al., influenc-
ing T cell responses through Ag-independent modulation of 
T cell survival and proliferation, as well as MHC-restricted Ag 
presentation. Interestingly, these functions, which are required 
for the maintenance of immune homeostasis, are segregated 
among different ILC types and compartmentalized in different 
anatomical locations. Notably, the interaction of ILC with T cells 
is also bidirectional, since ILC survival and proliferation requires 
cytokines released by activated T cells.
NatUral iMMUNE dEFiCiENCiES 
dEraNGiNG HUMaN t CEll iMMUNitY
The unfolding of Ag-specific T cell immunity and their regulation 
critically depends on the formation of highly organized intercel-
lular junctions between APC and T cells, referred to as immune 
synapses (IS). The contribution of Kallikourdis et al. features the 
functions of these intercellular structures by illustrating the con-
sequences ensuing from inborn errors of their structural compo-
nents. Notably, IS instability caused by missing or dysfunctional 
components affects trafficking and functions of both APC and 
T cells and associate to autoimmunity and recurrent infections.
dEtriMENtal CoNSEQUENCES oF 
dEraNGEd t CEll iMMUNitY at 
diFFErENt BodY SitES aNd iMMUNE 
iNtErVENtioN
Although the actions of innate immune cells fulfills the need of 
initiating and maintaining protective T cell responses, the exces-
sive presence or activity of individual determinants may be detri-
mental to the host, because it could promote tissue destruction as 
in autoimmunity and allergy, or conversely, prevent the induction 
of protective immune responses against malignant tissues. The 
capacity of neutrophils, monocytes, and basophils to acquire dif-
ferent functional profiles in response to environmental triggers 
and also their role as “bystander activators,” can indeed become 
detrimental, as underscored by the role of basophils and MC in 
allergies and chronic inflammation (Sarfati et al.; Bulfone-Paus 
and Bahri), of monocyte/macrophages in rheumatoid arthritis 
(Roberts et  al.) and of neutrophils and DC in cancer (Clausen 
and Stoitzner; Leliefeld et al.). Based on this knowledge, it is pos-
sible to consider the possibility of exploiting different types of DC 
licensing for inhibiting autoimmunity or enhancing protective 
immunity against pathogens and tumors (Salio and Cerundolo; 
Gottschalk et al.). In line with this, Martin et al. expand on the 
promising finding that anticancer drugs act as APC modulators 
in antitumor immunity.
In a totally new vision, Biedermann et  al. comprehensively 
describe the causal link between skin commensals and atopic 
dermatitis, highlighting how activation of skin-resident DC and 
myeloid-derived suppressor cells by T cell-derived cytokines and 
microbial components exacerbates atopic dermatitis and the clinical 
benefits induced by therapeutic alteration of the skin microbiome.
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